Vanderbilt researchers study ivermectin as a possible treatment for COVID-19 | Health


NASHVILLE, TN (WSMV) – Vanderbilt University Medical Center is looking for people to participate in a study to see if ivermectin and other drugs can treat COVID-19.

Ivermectin is a medicine generally used to treat parasitic infections, especially in cattle. Could this be a treatment for COVID-19 in humans?

Carolyn Coleman was diagnosed with COVID in early November, a day ahead of her scheduled booster injection date.

“I am doubly vaccinated,” Coleman said. “I want to do whatever I can to help science advance and help people, you know, stay healthy.”

While Coleman has COVID-19, she decided to participate in the Activ-6 remote study and help COVID-19 in the long term. In the study, several hundred people across the country are receiving one of the three drugs.

  • Ivermectin
  • Fluvoamine (an antidepressant)
  • Fluticasone (treatment of asthma)
  • Participants may also be given a placebo

Coleman said she received fluticasone.

“I didn’t choose that one. He was chosen for me, ”Coleman said.

“There is so much misinformation out there about ivermectin,” said Dr. Parul Goyal, principal investigator of the study at Vanderbilt.

She said most of the people in the study are interested in ivermectin.

“The dose of ivermectin we use in the study is a relatively lower dose and it’s a prescription based on weight,” Goyal said.

Goyal said ivermectin comes in the form of a pill intended for humans. This is only 7 milligrams compared to what is given to animals like horses.

“The ivermectin that was available for cattle is much more dangerous,” Goval said. “The side effects are all the more important as the dose is very concentrated.”

“I didn’t feel any worse, but I was also on the mend anyway,” Coleman said.

She mentioned that she didn’t notice a difference in her symptoms with fluticasone, but she wouldn’t say no to ivermectin.

“I don’t know anything about ivermectin. I would have taken it because that was the deal I had made with the study, ”Coleman said.

To participate in the study, you must be at least 30 years old and have two symptoms related to COVID-19. To register, visit the website or dial 615-343-8010. is now with you on the road! Get the latest updates and videos, 4WARN weather forecasts, weather radar, special investigation reports, sports headlines and more from News4 Nashville.

>> Click / tap here to download our free mobile app.

Copyright 2021 WSMV (Meredith Company). All rights reserved.

Source link


Comments are closed.